LEDERMAN SETH Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
40
Insider Buys Sum
$1.11M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of LEDERMAN SETH

According to the SEC Form 4 filings, LEDERMAN SETH, being in a position of

  1. Chief Executive Officer at Tonix Pharmaceuticals Holding Corp.,
    оver the last 12 months, has bought 27000 shares for $372,980, and sold 0 shares,
    over all time since 2013-05-20, has bought 637063 shares for $1.57M, and sold 0 shares.

Biography of LEDERMAN SETH

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$372,9804100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-08-27PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
2,000
0.0122%
$13.79$27,580-31.93%
2026-06-09PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
5,000
0.0316%
$11.79$58,950+0.7%
2026-03-31PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
5,000
0.0342%
$12.62$63,100-11.27%
2026-03-18PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
15,000
0.1231%
$14.89$223,350-13.11%
2025-05-15PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
4,000
0.0509%
$21.55$86,200-19.57%
2022-06-29PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
20,000
0.0147%
$1.71$34,200-66.14%
2022-03-25PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
100,000
0.0033%
$0.24$24,500-85.39%
2021-09-28PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
12,000
<0.0001%
$0.61$7,320-66.66%
2021-03-24PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
16,733
<0.0001%
$1.32$22,088-51.21%
2020-12-30PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
35,000
0.0001%
$0.68$23,800+41.83%
2020-08-13PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
60,000
0.0002%
$0.91$54,600-14.11%
2019-12-03PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
20,000
1.2754%
$1.16$23,180-33.23%
2019-03-29PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
5,000
0.0005%
$2.49$12,440-90.58%
2019-03-26PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
25,000
0.0025%
$2.38$59,375-90.58%
2018-06-29PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
500
<0.0001%
$4.64$2,320-81.05%
2018-06-28PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
500
<0.0001%
$4.58$2,290-81.59%
2018-06-27PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
500
<0.0001%
$4.55$2,275-81.63%
2018-06-12PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
3,000
0.0002%
$4.37$13,110-80.16%
2018-05-25PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
4,000
0.0002%
$3.17$12,680-72.72%
2017-12-26PurchaseTonix Pharmaceuticals Holding Corp.
TNXP
Chief Executive Officer
5,300
0.0003%
$3.61$19,133-57.77%
Total: 45
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.